Edition:
United Kingdom

Aurobindo Pharma Ltd (ARBN.NS)

ARBN.NS on National Stock Exchange of India

573.90INR
23 May 2018
Change (% chg)

Rs-6.10 (-1.05%)
Prev Close
Rs580.00
Open
Rs579.90
Day's High
Rs588.00
Day's Low
Rs571.60
Volume
1,093,393
Avg. Vol
2,307,203
52-wk High
Rs809.45
52-wk Low
Rs503.05

Latest Key Developments (Source: Significant Developments)

Aurobindo Pharma Gets U.S. FDA Approval For Fondaparinux Sodium Injection
Wednesday, 27 Dec 2017 

Dec 27 (Reuters) - Aurobindo Pharma Ltd ::SAYS GETS U.S. FDA APPROVAL FOR FONDAPARINUX SODIUM INJECTION.  Full Article

Aurobindo Pharma gets U.S. FDA nod for esomeprazole magnesium DR capsules OTC
Tuesday, 17 Oct 2017 

Oct 17 (Reuters) - Aurobindo Pharma Ltd :Says ‍received final approval from U.S. FDA to manufacture esomeprazole magnesium delayed-release capsules OTC, 20mg​.Says ‍product will be launched immediately​.  Full Article

Aurobindo Pharma gets USFDA approval for drugs used for treatement of HIV-1 infection
Monday, 21 Aug 2017 

Aug 21 (Reuters) - Aurobindo Pharma Ltd :Receives USFDA tentative approval for Dolutegravir, Lamivudine & Tenofovir Disoproxil Fumarate tablets.Drugs used for treatement of HIV-1 infection along as a regimen in adults and pediatric patients weighing over 40 kgs.  Full Article

Aurobindo Pharma gets USFDA tentative approval for Dolutegravir
Thursday, 22 Sep 2016 

Aurobindo Pharma Ltd :Aurobindo Pharma receives USFDA tentative approval for Dolutegravir, allowing the product to be launched in the PEPFAR market.  Full Article

Aurobindo Pharma receives USFDA approval for Linezolid injection
Monday, 8 Aug 2016 

Aurobindo Pharma Ltd : Aurobindo Pharma receives USFDA approval for Linezolid injection . Product is expected to be launched by Q2 FY 2016-17 .  Full Article

Aurobindo Pharma gets USFDA approval for rosuvastatin calcium tablets
Wednesday, 20 Jul 2016 

Aurobindo Pharma Ltd : Aurobindo Pharma receives usfda approval for rosuvastatin calcium tablets .  Full Article

BRIEF-Ironwood And Allergan Announce Settlement With Aurobindo Pharma Resolving Linzess Patent Litigation

* IRONWOOD AND ALLERGAN ANNOUNCE SETTLEMENT WITH AUROBINDO PHARMA RESOLVING LINZESS (LINACLOTIDE) PATENT LITIGATION